FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient with Exposure History but Minimal Symptoms

Hubert H. Chuang; Dustin J. Emery; Richelle Millican Campbell; Yang Lu

doi:10.1097/RLU.0000000000003137

FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient with Exposure History but Minimal Symptoms

Hubert H. Chuang, Dustin J. Emery, Richelle Millican Campbell, Yang Lu

Nuclear Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

A 56-year-old woman with high-grade neuroendocrine small cell carcinoma had known contact history of COVID-19 about 16 days prior to the restaging PET/CT. The patient was instructed to self-quarantine for 14 days, and no COVID-19 test was performed. Upon arrival, the patient had low-grade fever of 37.1°C, but did not meet infection control criteria for COVID-19 testing, and it was approved to proceed with PET/CT. The FDG PET/CT images revealed new multifocal hypermetabolic bilateral pulmonary ground-glass opacities that are suggestive of COVID-19 pneumonia. Meanwhile, the patient's symptoms worsened, and a blood test later confirmed COVID-19 infection.

Original language	English (US)
Pages (from-to)	656-658
Number of pages	3
Journal	Clinical nuclear medicine
Volume	45
Issue number	8
DOIs	https://doi.org/10.1097/RLU.0000000000003137
State	Published - Aug 1 2020

Keywords

COVID-19
FDG PET/CT
infection

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000003137

Cite this

@article{c02efc6f86db4310a828378429efe49a,

title = "FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient with Exposure History but Minimal Symptoms",

abstract = "A 56-year-old woman with high-grade neuroendocrine small cell carcinoma had known contact history of COVID-19 about 16 days prior to the restaging PET/CT. The patient was instructed to self-quarantine for 14 days, and no COVID-19 test was performed. Upon arrival, the patient had low-grade fever of 37.1°C, but did not meet infection control criteria for COVID-19 testing, and it was approved to proceed with PET/CT. The FDG PET/CT images revealed new multifocal hypermetabolic bilateral pulmonary ground-glass opacities that are suggestive of COVID-19 pneumonia. Meanwhile, the patient's symptoms worsened, and a blood test later confirmed COVID-19 infection.",

keywords = "COVID-19, FDG PET/CT, infection",

author = "Chuang, {Hubert H.} and Emery, {Dustin J.} and Campbell, {Richelle Millican} and Yang Lu",

year = "2020",

month = aug,

day = "1",

doi = "10.1097/RLU.0000000000003137",

language = "English (US)",

volume = "45",

pages = "656--658",

journal = "Clinical nuclear medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

TY - JOUR

T1 - FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient with Exposure History but Minimal Symptoms

AU - Chuang, Hubert H.

AU - Emery, Dustin J.

AU - Campbell, Richelle Millican

AU - Lu, Yang

PY - 2020/8/1

Y1 - 2020/8/1

N2 - A 56-year-old woman with high-grade neuroendocrine small cell carcinoma had known contact history of COVID-19 about 16 days prior to the restaging PET/CT. The patient was instructed to self-quarantine for 14 days, and no COVID-19 test was performed. Upon arrival, the patient had low-grade fever of 37.1°C, but did not meet infection control criteria for COVID-19 testing, and it was approved to proceed with PET/CT. The FDG PET/CT images revealed new multifocal hypermetabolic bilateral pulmonary ground-glass opacities that are suggestive of COVID-19 pneumonia. Meanwhile, the patient's symptoms worsened, and a blood test later confirmed COVID-19 infection.

AB - A 56-year-old woman with high-grade neuroendocrine small cell carcinoma had known contact history of COVID-19 about 16 days prior to the restaging PET/CT. The patient was instructed to self-quarantine for 14 days, and no COVID-19 test was performed. Upon arrival, the patient had low-grade fever of 37.1°C, but did not meet infection control criteria for COVID-19 testing, and it was approved to proceed with PET/CT. The FDG PET/CT images revealed new multifocal hypermetabolic bilateral pulmonary ground-glass opacities that are suggestive of COVID-19 pneumonia. Meanwhile, the patient's symptoms worsened, and a blood test later confirmed COVID-19 infection.

KW - COVID-19

KW - FDG PET/CT

KW - infection

UR - http://www.scopus.com/inward/record.url?scp=85087531427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087531427&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000003137

DO - 10.1097/RLU.0000000000003137

M3 - Article

C2 - 32433162

AN - SCOPUS:85087531427

SN - 0363-9762

VL - 45

SP - 656

EP - 658

JO - Clinical nuclear medicine

JF - Clinical nuclear medicine

IS - 8

ER -

FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient with Exposure History but Minimal Symptoms

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this